Ampliphi Biosciences Corp (NASDAQ:APHB) released its quarterly earnings results on Monday. The company reported ($0.78) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.80) by $0.02, reports. The business had revenue of $0.03 million during the quarter. Ampliphi Biosciences Corp had a negative return on equity of 159.06% and a negative net margin of 11,193.10%.

Shares of Ampliphi Biosciences Corp (NASDAQ APHB) opened at 0.775 on Tuesday. The firm’s 50 day moving average price is $1.97 and its 200-day moving average price is $1.04. The company’s market capitalization is $5.14 million. Ampliphi Biosciences Corp has a 1-year low of $0.67 and a 1-year high of $19.90.

TRADEMARK VIOLATION NOTICE: “Ampliphi Biosciences Corp (APHB) Posts Earnings Results” was reported by Watch List News and is the sole property of of Watch List News. If you are viewing this news story on another website, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at

Ampliphi Biosciences Corp Company Profile

AmpliPhi Biosciences Corporation is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.

Receive News & Ratings for Ampliphi Biosciences Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.